Runner Diribe Welteji Banned for Missed Test
Ethiopian middle-distance runner Diribe Welteji has been banned from competition due to a missed drug test, casting a pall over the recent World Championships. Welteji, who won her 1500m semifinal at the 2024 Summer Olympics, is now sidelined because of the anti-doping violation, highlighting ongoing integrity challenges in track and field.
The Court of Arbitration for Sport (CAS) imposed a two-year ban on Diribe Welteji after World Athletics appealed a decision by Ethiopia's national anti-doping body that had initially cleared her. World Athletics had originally sought a more severe four-year suspension for the middle-distance runner. The violation stems from a failure to submit to a sample collection in February 2025. Doping control officers went to her home, but her husband informed them she was asleep, and they ultimately left without a sample. The CAS arbitrator ruled the failure was negligent, not intentional, citing language barriers and other technical departures from best practice during the attempted test. As a result of the ban, all of Welteji's results from February 25, 2025, have been nullified. This includes a silver medal she won in the 1500m at the 2025 World Athletics Indoor Championships in Nanjing. Her suspension is set to run until June 30, 2027, making her eligible to return in time to qualify for the 2028 Los Angeles Olympics. This suspension sidelines a significant talent in track and field. Welteji is the 2023 World Championships silver medalist in the 1500m and also won the inaugural world road mile title in 2023. She also finished fourth in the 1500m at the 2024 Paris Olympics. The ban is a consequence of violating "whereabouts" rules, a key component of out-of-competition drug testing. Elite athletes in a registered testing pool must provide authorities with their location for one hour every day for potential unannounced tests. Under World Athletics rules, any combination of three "whereabouts failures"—which can be a missed test or a failure to file accurate location information—within a 12-month period constitutes an anti-doping rule violation.
